PRKD1 and urinary bladder carcinoma: Protein kinase D (PKD) inhibitors, such as CID2011756 or CRT0066101, were shown to sensitize the drug-resistant cancer cells to platinum-based anticancer drugs [31] and to suppresses bladder cancer in vitro and in vivo [32].